ADAMTSL5
ADAMTS-like protein 5
Also known as: ATL5_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q6ZMM2
- Gene
- ADAMTSL5
- Canonical length
- 481 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
OverviewNCBI Gene
No narrative summary is available for ADAMTSL5 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
481 residues, UniProt reviewed canonical sequence.
>Q6ZMM2|ADAMTSL5
1 MGKLRPGRVE WLASGHTERP HLFQNLLLFL WALLNCGLGV SAQGPGEWTP WVSWTRCSSS
61 CGRGVSVRSR RCLRLPGEEP CWGDSHEYRL CQLPDCPPGA VPFRDLQCAL YNGRPVLGTQ
121 KTYQWVPFHG APNQCDLNCL AEGHAFYHSF GRVLDGTACS PGAQGVCVAG RCLSAGCDGL
181 LGSGALEDRC GRCGGANDSC LFVQRVFRDA GAFAGYWNVT LIPEGARHIR VEHRSRNHLA
241 LMGGDGRYVL NGHWVVSPPG TYEAAGTHVV YTRDTGPQET LQAAGPTSHD LLLQVLLQEP
301 NPGIEFEFWL PRERYSPFQA RVQALGWPLR QPQPRGVEPQ PPAAPAVTPA QTPTLAPDPC
361 PPCPDTRGRA HRLLHYCGSD FVFQARVLGH HHQAQETRYE VRIQLVYKNR SPLRAREYVW
421 APGHCPCPML APHRDYLMAV QRLVSPDGTQ DQLLLPHAGY ARPWSPAEDS RIRLTARRCP
481 GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAMTSL5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- cervix: 31 nTPM
- vagina: 23 nTPM
- heart muscle: 21 nTPM
- endometrium: 20 nTPM
- esophagus: 15 nTPM
- skeletal muscle: 14 nTPM
Single-cell type
- cardiomyocytes: 41 nCPM
- leydig cells: 23 nCPM
- decidual stromal cells: 20 nCPM
- peritubular myoid cells: 20 nCPM
- myonuclei: 18 nCPM
- esophageal apical cells: 14 nCPM
Immune cell
- naive CD4 T-cell: 2 nTPM
- memory CD4 T-cell: 1.6 nTPM
- gdT-cell: 1.4 nTPM
- naive CD8 T-cell: 1.3 nTPM
- memory CD8 T-cell: 1.1 nTPM
- MAIT T-cell: 0.9 nTPM
Brain region
- choroid plexus: 21 nTPM
- cerebellum: 7.8 nTPM
- basal ganglia: 7.7 nTPM
- hippocampal formation: 6.8 nTPM
- amygdala: 6.6 nTPM
- thalamus: 6.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADAMTSL5.
Disease | ImmuneIEDB
Conditions an epitope on ADAMTSL5 was assayed in.
- psoriasis T cell
ReferencesPubMed · IEDB
Publications for ADAMTSL5 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies.
2022 · Sci Rep · RCR 1.6 · 20 citations - SOX-5 Transcription Factor: a Novel Psoriatic Autoantigen Preferentially Found in Women.
2024 · ACR Open Rheumatol · RCR 0.5 · 3 citations - Author Correction: Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies.
2023 · Sci Rep · RCR 0.1 · 1 citations
Reference: T cellIEDB
1 publication
- Complimentary electrostatics dominate T-cell receptor binding to a psoriasis-associated peptide antigen presented by human leukocyte antigen C∗06:02.
2023 · J Biol Chem · RCR 0.7 · 6 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.45
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thrombospondin type-1 (TSP1) repeat
- Netrin domain
- Tissue inhibitor of metalloproteinases-like, OB-fold
- ADAMTS/ADAMTS-like, Spacer 1
- ADAMTS/ADAMTS-like
- Netrin module, non-TIMP type
- Thrombospondin type-1 repeat superfamily
- ADAMTS/ADAMTS-like, cysteine-rich domain 3
- ADAMTS and ADAMTS-like
- Thrombospondin type 1 domain
- UNC-6/NTR/C345C module
- ADAM-TS Spacer 1
- ADAMTS cysteine-rich domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADAMTSL5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAMTSL5 as an antibody target. Whether an autoantibody or antibody against ADAMTSL5 could matter depends on whether native ADAMTSL5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAMTSL5 is annotated as secreted, so native ADAMTSL5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ADAMTSL5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...